Andere Sprachen SanBio Company Limited

Aktien

A14SRH

JP3336750009

4592

Verzögert Japan Exchange Andere Börsenplätze 08:00:00 02.05.2024			% 5 Tage	% 1. Jan.
430 ^JPY	+2,38 %		+3,12 %	-38,75 %

19.03.	SANBIO COMPANY LIMITED : Jefferies & Co. bekräftigt seine Verkaufsbewertung	ZM
19.03.	Transcript : SanBio Company Limited, 2024 Earnings Call, Mar 19, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March	19.03.
SanBio Books Non-operating Income, Extraordinary Gains, Deferred Income Taxes in Fiscal 2024	19.03.
SanBio's FY2024 Attributable Net Loss Narrows on Lower Costs, Forex Gains	19.03.
Sanbio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending January 31, 2025, and Full Fiscal Year Ending January 31, 2025	18.03.
SanBio Liquidates Singapore Unit	14.02.
Sanbio Co., Ltd. Provides Update on Status of Manufacturing and Marketing Approval for Sb623 Chronic Traumatic Brain Injury Program in Japan	25.01.
SanBio to Cancel Certain Stock Options	10.01.
SanBio Logs Extraordinary Gain from Asset Sale of US Unit	21.12.
Sanbio Widens Nine-Month Attributable Net Loss	15.12.
Sanbio Cuts Staff Amid Restructuring of Overseas Subsidiary	15.12.
Sanbio Expects to Receive Regulatory Nod for Stem Cell Therapy Candidate in March 2024	15.12.
SanBio Company Limited Provides Update on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	14.12.
SanBio's Overseas Subsidiary to Carry Out Personnel Reduction by November	12.07.23
SanBio Co., Ltd. Updates on Status of Manufacturing and Marketing Approval for SB623 Chronic Traumatic Brain Injury Program in Japan	14.06.23
SanBio Company Limited Provides Consolidated Earnings Guidance for the First Half and Full Year Ending January 31, 2024	14.06.23
Japan Stock Market Remains Jittery Despite Damage Control; Toyota Industries Plummets 11% Over Fresh Data Scandal	20.03.23
SanBio to Wind Up Singapore Unit	20.03.23
SanBio's FY23 Loss Widens	20.03.23
Sanbio Company Limited Provides Consolidated Earnings Guidance for the First Half of Fiscal Year Ending January 31, 2024, and Full Fiscal Year Ending January 31, 2024	17.03.23
SanBio to Acquire, Cancel Over 100,000 Stock Options	23.02.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen SanBio Company Limited

Aktien

A14SRH

JP3336750009

4592

Andere Sprachen

Filter